Dr. Severin Schwan, Ph.D., has been Chief Executive Officer of Roche Holding AG and Roche Holdings, Inc. since March 2008. Dr. Schwan has been Group Chief Executive Officer of Roche Diagnostics Corporation since January 1, 2008. He served as the Chief Executive Officer of Roche Diagnostics Corporation since January 1, 2006. He served as Chief Executive Officer of Diagnostics Division at Roche Holding AG since January 2006. He served as Trainee of Corporate Finance at Roche Basel from 1993 to 1995, Head Finance & Administration at Roche Brussels from 1995 to 1998, Head Finance & Informatics of Roche Grenzach and Member of the Executive Board of Roche Deutschland Holding GmbH from 1998 to 2000. Dr. Schwan served as the Head, Global Finance & Services of Roche Diagnostics from 2000 to 2004. He served as the Head of Diagnostics Asia-Pacific of Roche Holding AG from 2004 to January 1, 2006. He served as the Head of Global Finance & Services for the Diagnostics Division from 2000 to 2004. He serves as the Chairman of the Board at Roche Holdings, Inc. He has been Vice-Chair and Lead Independent Director of Credit Suisse Group AG since April 28, 2017. He has been an Independent Director of Credit Suisse AG since July 22, 2014. He has been a Director of Roche Holdings, Inc. since April 29, 2008 and Roche Holding AG since March 5, 2013. He has been an Independent Director of Credit Suisse Group AG since May 9, 2014. He serves as the Chairman at Genentech, Inc. He served as a Member of Scientific Resource Board at Genentech, Inc. He served as Independent Director at Credit Suisse (USA), Inc He served as Director of Chugai Pharmaceutical Co. Ltd. Dr. Schwan holds a degree in Economics from University of Innsbruck, University of York and University of Oxford Mag. rer.soc.oec. (Innsbruck, 1991) and Law from University of Innsbruck Mag. iur. (Innsbruck, 1991) and Doctorate in Law from University of Innsbruck Research studies at University Louvain, Belgium Dr. iur. (Innsbruck, 1993).

 Business Administration and Management